Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-000403

Chair and CEO sold 25,580 shares at an average $69.85 ($1,786,644)

  • Chair and CEO acquired 25,580 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-02 Exercise or conversion : show line 1 in the form 10b5-1 +18,750 $22.76 $426,750 403,710 D
2025-01-02 Sale : show line 2 in the form 10b5-1 −18,750 $69.84 $1,309,500 384,960 D
2025-01-02 Exercise or conversion : show line 3 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-01-02 Sale : show line 4 in the form 10b5-1 −6,830 $69.86 $477,144 233,924 I
Open-market sales · 25,580 sh · avg $69.85 · $1,786,644

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-02 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −18,750 93,750 D
2025-01-02 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −6,830 225,460 I
Loading xslF345X05/wk-form4_1735948354.xml…